Increased expression of ubiquitin during adenosine 3',5'-cyclic monophosphate-induced differentiation of neuroblastoma cells in culture.
The role of ubiquitin in proliferation and differentiation of nerve cells has not been studied. An elevation of the intracellular level of adenosine 3',5'-cyclic monophosphate (cAMP) in neuroblastoma cells induces terminal differentiation in these cells. Therefore, in this study we investigated the changes in the level and subcellular distribution of ubiquitin during proliferation and differentiation of neuroblastoma cells. Prostaglandin E1, a stimulator of adenylate cyclase, plus beta-carotene, and 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone (Ro 20-1724), an inhibitor of cyclic nucleotide phosphodiesterase, plus beta-carotene were used to induce terminal differentiation in > 90% of neuroblastoma cells. Changes in ubiquitin level were studied by immunofluorescent staining using either a mouse monoclonal antibody or a rabbit polyvalent antibody to ubiquitin. Results showed that the dividing neuroblastoma cells contained very low levels of ubiquitin localized primarily in the cytoplasm. The intensity of cytoplasmic staining for ubiquitin markedly increased during cAMP-induced differentiation of neuroblastoma cells, being the highest at 4 days after treatment. The neurites of these differentiated cells were also stained, but the nuclei were not. We propose a hypothesis that higher levels of cytoplasmic ubiquitin are needed during cAMP-induced differentiation of neuroblastoma cells for the removal of proteins responsible for cell proliferation through rapid degradation and/or inhibition of transcription, later leading to terminal differentiation.
La Rosa
F G
FG
Center for Vitamins and Cancer Research, University of Colorado Health Sciences Center, Denver 80262-0276, USA.
Kumar
S
S
Prasad
K N
KN
D000818:Animals; D002454:Cell Differentiation; D000242:Cyclic AMP / Q000494:pharmacology*; D005455:Fluorescent Antibody Technique; D051379:Mice; D009447:Neuroblastoma / Q000378:metabolism* / Q000473:pathology*; D013194:Staining and Labeling; D013997:Time Factors; D014407:Tumor Cells, Cultured / Q000187:drug effects; D014452:Ubiquitins / Q000378:metabolism*
D014452:Ubiquitins; D000242:Cyclic AMP